Aster DM buys 14.21% of Bangladesh's STS Holdings for $44M
What's the deal? Aster DM Quality CareDealroom has a profile for this one. Try Dealroom →, formerly Aster DM HealthcareDealroom has a profile for this one. Try Dealroom →, has acquired a 14.21% stake in Bangladesh-based STS HoldingsDealroom has a profile for this one. Try Dealroom → for roughly $44.1 million in cash. The deal covers 22,727,584 equity shares, priced at the US dollar equivalent of BDT 273.45 each.
Who's involved? STS Holdings, incorporated in Bangladesh in 1997, operates in healthcare services and training. It reported turnover of BDT 10,534.24 million for the fiscal year ending March 31, 2026.
Why now? The acquisition sits within a Merger Framework Agreement signed on November 29, 2024. It also aligns with a Scheme of Amalgamation between Quality Care IndiaDealroom has a profile for this one. Try Dealroom → and Aster DM Healthcare, approved by the National Company Law Tribunal's Hyderabad bench on June 19, 2026.
By the numbers: STS Holdings has grown steadily, from BDT 7,777.02 million in turnover for the year ending March 2024 to BDT 8,902.8 million in 2025 and BDT 10,534.24 million in 2026.
What's the endgame? The stake expands Aster's international footprint into Bangladesh's healthcare market. The company confirmed the deal was conducted at arm's length; its promoters hold no interest in STS Holdings, and the transaction is not a related-party deal.
The signal: The move signals Aster's push beyond its core markets into South Asian healthcare, using a minority stake tied to a broader merger structure as a first step.
Read more: investywise.com
Image credit: Generated with Gemini
